-
Mashup Score: 0Subcutaneous plasma-derived C1 inhibitor for long-term prophylaxis during pregnancy and breast-feeding in a patient with factor XII hereditary angioedema - 8 month(s) ago
Hereditary angioedema (HAE) is a disabling and potentially life-threatening disorder characterized by recurrent attacks of swelling. It is often linked to a deficiency or lack of functionality of the C1 esterase inhibitor (C1-INH), which leads to elevated levels of bradykinin. However, HAE can also occur in the presence of normal levels and activity of C1-INH, which is known as nC1-INH-HAE. Up to 25% of nC1-INH-HAE cases exhibit mutations in the factor XII (FXII) gene that cause an increase in levels of activated FXII, which is involved in the production of bradykinin.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis - Critical Care - 10 month(s) ago
Angiopoietin-2 (Ang-2) is associated with vascular endothelial injury and permeability in the acute respiratory distress syndrome (ARDS) and sepsis. Elevated circulating Ang-2 levels may identify critically ill patients with distinct pathobiology amenable to targeted therapy. We hypothesized that plasma Ang-2 measured shortly after hospitalization among patients with sepsis would be associated…
Source: BioMed CentralCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Distinct profiles of host responses between plasma and lower respiratory tract during acute respiratory failure - 10 month(s) ago
Subphenotypes derived from plasma levels of host response biomarkers can predict patient-centred outcomes during acute respiratory failure (ARF) [1, 2]. However, it is not well studied whether plasma-defined ARF subphenotypes reflect biological processes in the lungs or whether they capture extrapulmonary processes [3]. Limited evidence suggests that plasma-derived subphenotypes may not represent…
Source: European Respiratory SocietyCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Convalescent plasma for people with COVID‐19: a living systematic review - Iannizzi, C - 2023 | Cochrane Library - 11 month(s) ago
Collapse all Expand all Background Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as a potential therapy for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regarding benefits and risks of this intervention is required. Objectives To assess the effectiveness and safety of…
Source: www.cochranelibrary.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations - 12 month(s) ago
SARS-CoV-2 antibody levels associated with reduced hospitalization risk remain undefined. Our outpatient COVID-19 convalescent plasma (CCP), placebo-controlled trial observed SARS-CoV-2 antibody levels decreasing 22-fold from matched donor units into post-transfusion seronegative recipients. Unvaccinated recipients were jointly stratified by a) early or late transfusion (≤ 5 or >5 days from…
Source: medRxivCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Optimal induction strategy in highly sensitized kidney transplant recipients (KTRs) is still a matter of debate. The place of therapies, such as plasma exchange and rituximab, with potential side effects and high cost, is not clearly established. We compared two induction strategies with (intensive) or without (standard) rituximab and plasma exchange in KTRs with high levels of preformed DSA…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet
-
Mashup Score: 0
The pandemic COVID-19 has spread widely throughout the globe and has been responsible for millions of deaths worldwide. Recently, it has been identifi…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 3
The pandemic COVID-19 has spread widely throughout the globe and has been responsible for millions of deaths worldwide. Recently it has been identifie…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Convalescent plasma for people with COVID‐19: a living systematic review - Iannizzi, C - 2023 | Cochrane Library - 1 year(s) ago
Collapse all Expand all Background Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as a potential therapy for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regarding benefits and risks of this intervention is required. Objectives To assess the effectiveness and safety of…
Source: www.cochranelibrary.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers - 1 year(s) ago
This prognostic study uses data from the Swedish BioFINDER-1 and Wisconsin Registry for Alzheimer Prevention longitudinal cohort studies to evaluate whether combinations of different plasma biomarkers can predict cognitive decline in cognitively unimpaired individuals with β-amyloid positivity.
Source: jamanetwork.comCategories: Healthcare Professionals, Latest HeadlinesTweet
In Current Issue! #Subcutaneous #plasma-derived C1 #inhibitor for #long-#term #prophylaxis during #pregnancy and breast-feeding in a #patient with factor XII #hereditary #angioedema https://t.co/y71qdtxc4x